Close Menu

NEW YORK (GenomeWeb) – Using capture-based targeted sequencing, researchers at Columbia University have developed a method that can identify all known pathogenic bacteria from clinical samples as well as known resistance and virulence factors.

The technique reportedly lowers the limit of detection compared to unbiased high-throughput sequencing and results in a 1,000-fold increase in bacterial reads from blood samples.   

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.